Last updated 2 months ago
Brightline-4: A Study to Test How Well Brigimadlin is Tolerated by People With a Type of Cancer Called Dedifferentiated Liposarcoma
240 patients around the world
Available in Argentina
Boehringer Ingelheim
7Research sites
240Patients around the world
This study is for people with
Liposarcoma
Dedifferentiated Liposarcoma
Requirements for the patient
From 18 Years
All Gender
Medical requirements
Sites
Hospital Británico de Buenos Aires - CABA
Recruiting
Hospital Italiano de Buenos Aires - CABA, Buenos Aires
Recruiting
Instituto Médico Especializado Alexander Fleming - CABA, Buenos Aires
Recruiting
Sanatorio Finochietto
Recruiting
Hospital Do Cancer de Londrina
Recruiting
Hospital São Domingos
Recruiting
Beneficência Portuguesa de São Paulo
Recruiting
StudyBrightline-4
SponsorBoehringer Ingelheim
Conditions
Dedifferentiated Liposarcoma
Requirements
From 18 YearsAll Gender
Unique study IDclinicaltrials.gov
NCT06058793
